Biophan
Gruß,
ZACC
Optionen
| Boardmail an "zacc" |
Wertpapier: Biophan Technologies |
Optionen
| Boardmail an "zacc" |
Wertpapier: Biophan Technologies |
Wer risiko freudig ist und auf gute gewinne erhofft muss einfach bei
der aktie investiert sein!!!!!
Nach dem die aktie in letzter zeit sehr gute performence hingelegt hat konsolidiert die aktie sich zwischen 0.80 - 1 € gutes zeichen für weitere kurssteigerung!!!
Man sollte bei dem wert investiert sein den in den nächsten Zeiten stehen die tore
bis 1.60 € offen!
Damit man aber keine böse überraschung erlebt sollte ein stop-los bei 0.79 € setzen!
P.S : Wie heist es so schön gegen risiko absichern und gewinne mitnehmen
da machen wir garnichts falsch , die wird noch richtig gehen !
Gruß
leo
In den letzten wochen waren bei der aktie die bären am drücker sie haben es nicht geschaft nur annähernd die 0.80 cent marke zu drücken keiner will abgeben.Also müssen
andere kurse laufen damit man sicht wo es lang geht.Wie gesagt in den den nächsten 3 monaten sollte schonmal die 1.60 € rausspringen wenn es gut geht sogar 2 €.
P.S : Wenn erstmal die fondsmanager die aktie richtig entdecken und anfangen sich paar aktien ins depot zu legen dann geht die party erst richtig los!!!!!
In diesem sinne auf gute gewinne
Nächster stop währe 1.60$ bis 2$
Also anschnallen und festhalten den die party könnte losgehen
Gruß Black panter
Friday March 5, 4:06 pm ET
Biophan present at the Nanotech Early Stage Industry Review at 7:00 p.m. on Monday March 8, 2004
ROCHESTER, N.Y.--(BUSINESS WIRE)--March 5, 2004--Biophan Technologies, Inc. (OTCBB: BIPH - News) an innovator, developer and marketer of MRI-related and other advanced biomedical technology, announced today that it will present at the Nanotech 2004 Conference being held March 7-9, 2004, at the Boston Sheraton Hotel in Boston, MA. Michael Weiner, Biophan's CEO, will present at the Nanotech Early Stage Industry Review at 7:00 p.m. on Monday, March 8, 2004.
Biophan's technologies include filtering, shielding, coating, imaging, and photonic solutions to both MRI safety and MRI image compatibility. NanoView(TM), Biophan's newest technology, will utilize nanomagnetic particles as contrast agents that preferentially bind to tissues of diagnostic interest, creating improved detail and contrast in images. Mr. Weiner will give an overview of this recently acquired technology and other nanotechnology capabilities that may influence the biomedical device industry in the near future. (http://www.nanotech2004.com/2004program/showabstract.html?absno=996)
About Biophan Technologies
Biophan Technologies develops and markets cutting-edge technologies used to make biomedical devices--such as cardiac pacemakers, surgical and diagnostic tools--safe and compatible with magnetic resonance imaging (MRI) equipment. The technology is also being used to create enhanced MRI contrast agents. Committed to growth through innovation and developmental leadership, Biophan and its licensors have four issued U.S. patents and over fifty patents pending, in areas including nanomagnetic particle coatings, radio frequency filters, polymer composites, and photonics. Biophan's technology will help realize its goal of one day making all biomedical devices capable of safely and successfully working with MRI. For more information, please visit www.biophan.com.
About This Conference
For more information on this conference, please visit http://www.nanotech2004.com.
Safe Harbor Statement:
Certain statements included in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ materially from such statements expressed or implied herein as a result of a variety of factors including, but not limited to: the development of the Company's MRI technologies; the approval of the Company's patent applications; the successful implementation of the Company's research and development programs; the acceptance by the market of the Company's products; competition and the timing of projects and trends in future operating performance, as well as other factors expressed from time to time in the Company's periodic filings with the Securities and Exchange Commission (the "SEC"). As a result, this press release should be read in conjunction with the Company's periodic filings with the SEC. The forward-looking statements contained herein are made only as of the date of this press release, and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances. das beste was passieren könnte nach der conference,das biophan bald an der nasdag oder amex gelisstet wird schneller als wir denken!hoffnung ist alles!Mfg azel
meine 10000 Stücke erst bei 17 $.